Subjects: TOXINAS, DISFUNÇÃO TEMPOROMANDIBULAR, DOR FACIAL, SÍNDROMES DA DOR MIOFASCIAL, MANDÍBULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANALES, Giancarlo De la Torre et al. Efficacy of botulinum toxin type-A I in the improvement of mandibular motion and muscle sensibility in myofascial pain TMD subjects: a randomized controlled trial. Toxins, v. 14, n. 7, p. 9 , 2022Tradução . . Disponível em: https://doi.org/10.3390/toxins14070441. Acesso em: 18 ago. 2024.APA
Canales, G. D. la T., Poluha, R. L., Alvarez Pinzón, N., Silva, B. R. da, Almeida, A. M., Ernberg, M., et al. (2022). Efficacy of botulinum toxin type-A I in the improvement of mandibular motion and muscle sensibility in myofascial pain TMD subjects: a randomized controlled trial. Toxins, 14( 7), 9 . doi:10.3390/toxins14070441NLM
Canales GD la T, Poluha RL, Alvarez Pinzón N, Silva BR da, Almeida AM, Ernberg M, Manso AC, Bonjardim LR, Rizzatti-Barbosa CM. Efficacy of botulinum toxin type-A I in the improvement of mandibular motion and muscle sensibility in myofascial pain TMD subjects: a randomized controlled trial [Internet]. Toxins. 2022 ; 14( 7): 9 .[citado 2024 ago. 18 ] Available from: https://doi.org/10.3390/toxins14070441Vancouver
Canales GD la T, Poluha RL, Alvarez Pinzón N, Silva BR da, Almeida AM, Ernberg M, Manso AC, Bonjardim LR, Rizzatti-Barbosa CM. Efficacy of botulinum toxin type-A I in the improvement of mandibular motion and muscle sensibility in myofascial pain TMD subjects: a randomized controlled trial [Internet]. Toxins. 2022 ; 14( 7): 9 .[citado 2024 ago. 18 ] Available from: https://doi.org/10.3390/toxins14070441